Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Alexion Pharmaceuticals, Inc.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Documented BAG3 mutation that causes or is likely to cause dilated cardiomyopathy
Heart failure Stage B-D, New York Heart Association (NYHA) Class I-IV
Left Ventricular Ejection Fraction ≤50% (i.e., Reduced Heart Function)
You may not be if
Acute decompensated heart failure within 1 month prior to enrollment.(such as hospitalization)
Any of the following within 3 months prior to screening: myocardial infarction (MI), cardiac surgical procedures (other than for pacemaker/ICD/CRT-defibrillator \[CRT-D\] implantation), acute coronary syndrome, or hospitalization for cardiac arrhythmia.